STIM files Form 144 for proposed sale of 192,806 shares on NASDAQ

Rhea-AI Filing Summary

Neuronetics, Inc. (STIM) filed a Form 144 reporting a proposed sale of 192,806 common shares with an aggregate market value of $717,238.32. The filing states the sale is expected on or about 08/08/2025 on NASDAQ and lists Morgan Stanley Smith Barney LLC as the broker. The shares were acquired on 12/10/2024 in a merger/acquisition transaction from the issuer and were paid for in cash. The filing reports 66,124,820 shares outstanding and notes Nothing to Report for sales in the past three months.

Insights

Securities Analyst

TL;DR: Routine Form 144 disclosure; proposed sale disclosed and appears limited in size.

The Form 144 provides standard Section 144 disclosure of a proposed sale of 192,806 shares valued at $717,238.32. It notes the shares were acquired on 12/10/2024 in a merger/acquisition and paid in cash. The filing identifies the executing broker and an approximate sale date of 08/08/2025. There are no reported sales in the prior three months. Based solely on the filing, this is a routine notification meeting Rule 144 requirements.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144; no immediate governance concerns evident from this notice.

The notice documents provenance of the shares (acquired from the issuer in a merger/acquisition) and includes the required representations about material nonpublic information. The broker and expected execution venue are specified. Because the filing contains no additional disclosures of insider transactions or recent sales, it does not by itself indicate governance issues. The filing should be viewed as a compliance disclosure tied to a planned sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	192806	717238.32	66124820	08/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/10/2024	Merger/Acquisition	Issuer			192806	12/10/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Neuronetics (STIM) file in this Form 144?

The Form 144 notifies a proposed sale of 192,806 common shares with an aggregate market value of $717,238.32.

When and where is the sale expected to occur for STIM?

The filing lists the approximate sale date as 08/08/2025 and the venue as NASDAQ.

How were the shares being sold acquired according to the filing?

The shares were acquired on 12/10/2024 in a merger/acquisition transaction from the issuer and paid for in cash.

Who is the listed broker handling the proposed sale for STIM?

The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza 8th Floor New York NY 10004.

Were there any sales by the filer in the past three months reported?

The filing states Nothing to Report for securities sold during the past three months.